1328 Results for "

accumulation

" in MedChemExpress (MCE) Product Catalog:
Products (1328)

1328 Results for "accumulation" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-141659
CAS No.: 2242582-40-5
Purity:  99.74%
Research Areas:  

Neurological Disease

CMPD-39 is a selective non-covalent inhibitor of the ubiquitin-specific protease USP30 (IC50=~20 nM), with high selectivity over other DUB family members (1-100 μM). CMPD-39 inhibits the deubiquitinating activity of USP30, enhances the ubiquitination of mitochondrial proteins TOMM20 and SYNJ2BP; thus, CMPD-39 promotes phosphoubuitin accumulation, thereby accelerating mitochondrial autophagy (mitophagy) and peroxisomal autophagy (pexophagy). CMPD-39 significantly restores impaired mitochondrial function in dopaminergic neurons derived from Parkinson's disease patients .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-N8518
CAS No.: 63335-25-1
Malabaricone C is an orally active and noncompetitive sphingomyelin synthase (SMS) inhibitor with IC50 values of 3 μM and 1.5 μM for SMS 1 and SMS 2, respectively. Malabaricone C reduces body weight gain, improves glucose tolerance, and decreases lipid accumulation in the liver, showing significant prevention of high fat diet-induced fatty liver in mice. Malabaricone C has anti-inflammatory effects, which is found in the fruits of Myristica cinnamomea King. Malabaricone C is promising for research of obesity and immunological disorders caused due to hyper-activation of T-cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-103430A
CAS No.: 99295-33-7
Purity:  99.82%
SKF-83566 is an orally active, blood-brain barrier-permeable D1/D5 dopamine receptor antagonist with a Ki value of approximately 0.4-0.56 nM. SKF-83566 modulates locomotor behavior and spatial memory by blocking D1 receptors and inhibits glioblastoma progression by targeting the DRD1/c-Myc/UHRF1 pathway. SKF-83566 acts as an inhibitor of the dopamine transporter (DAT) and adenylyl cyclase 2 (AC2). SKF-83566 competitively binds to DAT to inhibit dopamine reuptake and non-competitively inhibits AC2 activity, thereby reducing cAMP accumulation. SKF-83566 is used in research areas such as dopaminergic system mechanisms, learning and memory, targeted intervention for glioblastoma, AC2 pathophysiology, antiparasitic drug screening, and synaptic plasticity (the "gating effect") .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-100200
CAS No.: 307538-42-7
Purity:  99.92%
Target:  

Autophagy

Research Areas:  

Cancer

SMER28 is a positive regulator of autophagy acting via an mTOR-independent mechanism. SMER28 prevents the accumulation of amyloid beta peptide.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-50289
CAS No.: 68367-52-2
Target:  

Aldose Reductase

Research Areas:  

Metabolic Disease

Sorbinil is an aldose reductase inhibitor (ARI) that prevents the accumulation of sorbitol in cells or animals. Sorbinil is useful in studying diabetes and diabetic complications, reducing AR activity and inhibiting the polyol pathway.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-135008
CAS No.: 1043854-13-2
Purity:  99.06%
Research Areas:  

Cancer

J14 is a reversible sulfiredoxin inhibitor with an IC50 of 8.1 μM. J14 induces oxidative stress (intracellular ROS accumulation) by inhibiting sulfiredoxin, leading to cytotoxicity and cancer cell death .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-121885
CAS No.: 950195-51-4
Purity:  99.35%
Target:  

CCR

Research Areas:  

Metabolic Disease Endocrinology

LMD-009 is a selective CCR8 nonpeptide agonist. LMD-009 mediates chemotaxis, inositol phosphate accumulation, and calcium release in high potencies with EC50s from 11 to 87 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1730
CAS No.: 86-34-0
Phensuximide is an orally active succinimide antiepileptic and anticonvulsant agent. Phensuximide inhibits cyclic AMP and cyclic GMP accumulation in depolarized brain tissue. Phensuximide can be used for the study of seizure and petit mal .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-139369
CAS No.: 2132411-21-1
Purity:  98.11%
Research Areas:  

Cancer

QD394 is a reactive oxygen species (ROS) inducer that can induce lipid peroxidation, increase intracellular ROS accumulation, inhibit STAT3 phosphorylation, and induce ferroptosis .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W004494
CAS No.: 141120-17-4
Research Areas:  

Others

2-Aminoindan-2-phosphonic acid is an inhibitor of phenylalanine ammonia-lyase (PAL). 2-Aminoindan-2-phosphonic acid reduces the biosynthesis and accumulation of total phenolic compounds in the suspension cell culture system of Cistanche .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-138188
CAS No.: 10161-87-2
Purity:  98.73%
Target:  

Ras

Research Areas:  

Cancer

KRA-533 is a potent KRAS agonist. KRA-533 binds to the GTP/GDP binding pocket in the KRAS protein to prevent GTP cleavage, resulting in the accumulation of constitutively active GTP-bound KRAS that triggers both apoptotic and autophagic cell death pathways in cancer cells.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10559
CAS No.: 839713-36-9
Purity:  99.52%
Synonyms: APD125
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease Cancer

Nelotanserin is a potent 5-HT2A inverse agonist, a moderately potent 5-HT2C partial inverse agonist and a weak 5-HT2B inverse agonist, with IC50s of 1.7, 79, 791 nM in IP accumulation assays, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-Y1092
CAS No.: 538-75-0
N,N-Dicyclohexylcarbodiimide(DCC) is a dehydrating and condensing agent. N,N-Dicyclohexylcarbodiimide(DCC) enhances adenylate cyclase activity. N,N-Dicyclohexylcarbodiimide(DCC) inhibits amine accumulation. N,N-Dicyclohexylcarbodiimide(DCC) is used to prepare 3-phenylcoumarin derivatives, sulfated derivatives of purslane polysaccharides .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-33893
CAS No.: 22259-53-6
Indole-3-methanamine is an indole derivative, stress-related metabolite, and also a biosynthetic precursor of Gramine (HY-N0166). The accumulation level of Indole-3-methanamine increases in susceptible barley varieties infected with Bipolaris sorokiniana. Indole-3-methanamine can be used in studies related to barley spot blotch .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-123402
CAS No.: 264206-85-1
Purity:  99.19%
Target:  

LXR

Research Areas:  

Metabolic Disease

GSK3987 is a pan LXRα/β agonist with EC50s of 50 nM, 40 nM for LXRα-SRC1 and LXRβ-SRC1, respectively. GSK3987 increases the expression of ABCA1 and SREBP-1c. GSK3987 induces cellular cholesterol efflux and triglyceride accumulation .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W016562
CAS No.: 495-69-2
Synonyms: Benzoylglycine
Hippuric Acid is an orally active metabolite. Hippuric Acid can be produced by intestinal microorganisms from the metabolism of polyphenols, benzoic acid. Hippuric Acid decreases NRF2, MMP9 and leads to ROS accumulation. Hippuric Acid activates TGFβ/SMAD signaling. Hippuric Acid improves hyperuricemia and colitis. Hippuric Acid can also be used in cardiovascular disease research . .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-W014841
CAS No.: 532-94-5
Synonyms: N-Benzoylglycine sodium, 98%
Sodium hippurate, 98% is an orally active metabolite. Sodium hippurate, 98% can be produced by intestinal microorganisms from the metabolism of polyphenols, benzoic acid. Sodium hippurate, 98% decreases NRF2, MMP9 and leads to ROS accumulation. Sodium hippurate, 98% activates TGFβ/SMAD signaling. Sodium hippurate, 98% improves hyperuricemia and colitis. Sodium hippurate, 98% can also be used in cardiovascular disease research . .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-137458
CAS No.: 1416775-46-6
Purity:  98.03%
Synonyms: ARQ 751
Target:  

Akt CDK TGF-beta/Smad

Research Areas:  

Cancer

Vevorisertib (ARQ 751) is an orally active allosteric AKT inhibitor that blocks AKT phosphorylation. Vevorisertib inhibits tumor cell proliferation through Cyclin D1 and Ki67. Vevorisertib inhibits liver fibrosis through collagen accumulation, alpha-SMA, COL1, and TGF-beta. Vevorisertib reduces total bilirubin. Vevorisertib significantly reduces tumor size in a cirrhotic rat HCC model. Vevorisertib can be used for research on hepatocellular carcinoma .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-137458A
CAS No.: 1416775-08-0
Purity:  99.13%
Synonyms: ARQ 751 trihydrochloride
Target:  

Akt CDK TGF-beta/Smad

Research Areas:  

Cancer

Vevorisertib trihydrochloride (ARQ 751 trihydrochloride) is an orally active allosteric AKT inhibitor that blocks AKT phosphorylation. Vevorisertib trihydrochloride inhibits tumor cell proliferation through Cyclin D1 and Ki67. Vevorisertib trihydrochloride inhibits liver fibrosis through collagen accumulation, alpha-SMA, COL1, and TGF-beta. Vevorisertib trihydrochloride reduces total bilirubin. Vevorisertib trihydrochloride significantly reduces tumor size in a cirrhotic rat HCC model. Vevorisertib trihydrochloride can be used for research on hepatocellular carcinoma .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1113
CAS No.: 333-41-5
Synonyms: Dimpylate
Research Areas:  

Infection

Diazinon is an orally active, irreversible AChE inhibitor and insecticide that can be absorbed through the digestive system, skin or respiratory tract. Diazinon inhibits AChE, leading to accumulation of acetylcholine, which in turn overstimulates ACh receptors and affects the nervous system. Diazinon also produces reactive oxygen species (ROS), which induce oxidative stress in various tissues. Diazinon is mainly used in the agricultural field as an insecticide and may have potential effects on human and animal health .
loading...
    loading...